Chao Shang

机构：Xidian University · ORCID：0000-0002-9006-8492

发表论文 86 篇 · 总被引 1923 次 · h-index 24

代表论文

• Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model (2023 · Virology Journal · 被引 14)
• Inhibition of multiple SARS-CoV-2 variants entry by Lycium barbarum L. polysaccharides through disruption of spike protein-ACE2 interaction (2024 · International Journal of Biological Macromolecules · 被引 12)
• AGCM-22, a novel cetuximab-based EGFR-targeting antibody-drug-conjugate with highly selective anti-glioblastoma efficacy (2024 · Bioorganic & Medicinal Chemistry · 被引 10)
• Manidipine is not a potential inhibitor against SARS-CoV-2 main protease (2024 · Antimicrobial Agents and Chemotherapy · 被引 8)
• Role and clinical significance of immunogenic cell death biomarkers in chemoresistance and immunoregulation of head and neck squamous cell carcinoma (2023 · Biomedicine & Pharmacotherapy · 被引 8)
• A novel antibody-KSP inhibitor conjugate improves KSP inhibitor efficacy in vitro and in vivo (2023 · Biomaterials · 被引 7)